Decibel Therapeutics Public
Translating rapid advances in hearing science to meet the urgent needs of hundreds of millions worldwide with disabling hearing loss.
Technology:
Other
Funding Status:
IPO
Number Of Exists:
51-100
Investor Type:
IPO
Investors Number:
16
Employee Number:
51-100
Last Funding Date:
2020
Headquarters:
Cambridge, Massachusetts, United States
Last Funding Type:
Series D
Total Funding:
189.2M
Founded Date:
2015
Industry:
PharmTech
Estimated Revenue:
$10M to $50M